Skip to Main Content

Paper Details

Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study.
Lung Cancer
2
2023
Author NameAffiliation
Ramaswamy GovindanWashington University School of Medicine
  • 1 - 1

Datasets

Release 1.2